Working... Menu

Belimumab With Rituximab for Primary Membranous Nephropathy (REBOOT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03949855
Recruitment Status : Not yet recruiting
First Posted : May 14, 2019
Last Update Posted : May 16, 2019
Immune Tolerance Network (ITN)
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)

No Study Results Posted on for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : March 2024
  Estimated Study Completion Date : December 2024